Khaleva, E. et al. (2023) Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA). European Respiratory Journal, 61(4), 2200606. (doi: 10.1183/13993003.00606-2022) (PMID:36229046) (PMCID:PMC10069873)
Text
283995.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 1MB |
Abstract
Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) working group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies. COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult, and paediatric clinicians, pharmaceutical representatives and health regulators from across Europe. Evidence included a systematic review of development, validity, and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients' and carers' views about outcome measures. It was discussed using a modified GRADE Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria. Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV ) as z scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire, and Asthma Control Test (ACT) or Childhood-ACT while the adult COM includes the Severe Asthma Questionnaire and the Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately). This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Paton, Dr James and Chaudhuri, Dr Rekha |
Authors: | Khaleva, E., Rattu, A., Brightling, C., Bush, A., Bossios, A., Bourdin, A., Chung, K. F., Chaudhuri, R., Coleman, C., Dahlén, S.-E., Djukanovic, R., Deschildre, A., Fleming, L., Fowler, S. J., Gupta, A., Hamelmann, E., Hashimoto, S., Hedlin, G., Koppelman, G. H., Melén, E., Murray, C. S., Pilette, C., Porsbjerg, C., Pike, K. C., Rusconi, F., Williams, C., Ahrens, B., Alter, P., Anckers, F., van den Berge, M., Blumchen, K., Brusselle, G., Clarke, G. W., Cunoosamy, D., Dahlén, B., Dixey, P., Exley, A., Frey, U., Gaillard, E. A., Giovannini-Chami, L., Grigg, J., Hartenstein, D., Heaney, L. G., Karadag, B., Kaul, S., Kull, I., Licari, A., Maitland-van der Zee, A. H., Mahler, V., Schoos, A.-M. M., Nagakumar, P., Negus, J., Nielsen, H., Paton, J., Pijnenburg, M., Ramiconi, V., Vilarnau, S. R., Principe, S., Rutjes, N., Saglani, S., Seddon, P., Singer, F., Staudinger, H., Turner, S., Vijverberg, S., Winders, T., Yasinska, V., and Roberts, G. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | European Respiratory Journal |
Publisher: | European Respiratory Society |
ISSN: | 0903-1936 |
ISSN (Online): | 1399-3003 |
Published Online: | 13 October 2022 |
Copyright Holders: | Copyright © The authors 2023 |
First Published: | First published in European Respiratory Journal 61(4): 2200606 |
Publisher Policy: | Reproduced under a Creative Commons licence |
University Staff: Request a correction | Enlighten Editors: Update this record